UPDATE 2-GSK's long acting HIV injection gets boost from study

* GSK up against competition from Gilead's 3-drug combo (Releads, adds background on rivalry with Gilead)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.